Kuby Immunology: Detailed Notes on Cell-Mediated Cytotoxic Responses
Chapter 14: Cell-Mediated Cytotoxic Responses
Introduction
- The sixth edition of Kuby Immunology provides insights into the mechanisms of cell-mediated cytotoxicity, detailing the roles of T cells and their interactions with antigen-presenting cells.
Section 1: Characteristics of T Cells
Comparison of Naive and Effector T Cells (Table 14-1)
Costimulatory Signal:
- Naive T cells: Required activation through interaction between CD28 and B7.
- Effector T cells: Not required for activation.
CD45 Isoform:
- Naive T cells: CD45RA isoform.
- Effector T cells: CD45RO isoform.
Cell Adhesion Molecules:
- Naive T cells: Low expression of adhesion molecules (e.g., CD2, LFA-1).
- Effector T cells: High expression of adhesion molecules.
Trafficking Patterns:
- Naive T cells: Homing to high-endothelial venules (HEVs) in secondary lymphoid tissues.
- Effector T cells: Migration to tertiary lymphoid tissues and inflammatory sites.
Section 2: Effector Molecules of T Cells (Table 14-2)
Types of Effectors Produced by Effector T Cells
Cytotoxic T Lymphocytes (CTLs):
- Soluble Effectors:
- Cytotoxins (perforins and granzymes), IFN-γ, TNF-β.
- Membrane-Bound Effectors:
- Fas ligand (FASL).
T Helper 1 (TH1) Cells:
- Soluble Effectors:
- IL-2, IL-3, TNF-β, IFN-γ, GM-CSF (high levels).
T Helper 2 (TH2) Cells:
- Soluble Effectors:
- IL-3, IL-4, IL-5, IL-6, IL-10, IL-13, GM-CSF (low levels).
- Membrane-Bound Effects:
- CD40 ligand.
Section 3: Activation and Licensing of CTLs
CTL Activation
- Activation Process:
- Requires licensing of antigen-presenting dendritic cells for co-stimulatory signaling (Figure 14-1).
- Signals provided by helper T cells (specifically TH1) enhance CTL activation:
- Dendritic cells deliver a 'stronger' signal to naive CTL precursor cells (CTL-P).
Memory CTLs
- Memory CTL precursors do not require helper T cells for activation; remain responsive due to past exposures (Figure 14-2).
Section 4: CTL Mechanisms of Action
Conjugate Formation
- CTLs form conjugates with target cells to initiate cytotoxic action (Figure 14-6).
- Mechanisms of granule exocytosis leading to target cell lysis include:
- Granule Conjugate Formation:
- CTL binds to target cell, leading to localized cytoplasmic rearrangement.
- Exocytosis of Cytotoxic Granules:
- Release of perforins and granzymes directed at the target cell (Figure 14-9).
- Granule Conjugate Formation:
Perforin and Granzymes
Perforin Pathway:
- Perforins polymerize to form pores in the target cell membrane, facilitating protein entry (Figure 14-9a).
Granzyme Activation:
- Granzymes enter via the perforin-created pores and activate apoptotic pathways:
- Trigger caspase cascades and subsequent cellular apoptosis (Figure 14-11).
Pathways of Apoptosis
Fas Pathway (Figure 14-11a):
- Involves Fas ligand (FasL) binding to Fas receptor.
- FADD complex activates downstream caspases leading to apoptosis.
Perforin/Granzyme Pathway (Figure 14-11b):
- Granzymes enter through perforin-formed pores, activate procaspases, leading to apoptosis.
Section 5: Innate Immunity: Role of NK Cells
Natural Killer (NK) Cells
- Functions and activation through MHC Class I recognition (Figure 14-14).
- NK cells differentiate between normal and infected cells based on MHC expression.
- Inhibit killing signal when Class I MHC is present (Figure 14-14a) but initiate killing when absent or downregulated (Figure 14-14b).
Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC)
- Mechanisms and involved cell types (NK cells, macrophages, etc.) that target cells marked by antibodies (Figure 14-15).
Section 6: Bridging of Innate and Adaptive Immunity
NKT Cells
- NKT cells bridge both immune systems, characterized by:
- Expression of T cell receptors (TCRs) responding to glycolipid antigens activated by CD1d molecules.
- Function as both helper and cytotoxic cells without forming memory cells.
Conclusion
- CTLs and NK cells play significant roles in the immune system's ability to combat infections and clear malignancies.
- Understanding the pathways of activation, recognition, and cytotoxic mechanisms provides insight into therapeutic strategies for infectious diseases and cancer.